We are live on
!
Find out more
CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.67B
1-Year Est. Return
89%
This Fund
S&P 500
This Quarter
Est. Return
+22.56%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$295M
AUM Growth
+$46.7M
(+19%)
Cap. Flow
+$5.84M
Cap. Flow
% of AUM
1.98%
Top 10 Holdings %
Top 10 Hldgs %
32.39%
Holding
456
New
65
Increased
317
Reduced
38
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$6.09M |
| 2 |
PayPal
PYPL
|
+$4.84M |
| 3 |
STAAR Surgical
STAA
|
+$3.72M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$3.18M |
| 5 |
Microsoft
MSFT
|
+$2.94M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$7.85M |
| 2 |
iQIYI
IQ
|
+$7.2M |
| 3 |
ON Semiconductor
ON
|
+$4.1M |
| 4 |
Apple
AAPL
|
+$2.75M |
| 5 |
uniQure
QURE
|
+$2.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.43% |
| 2 | Consumer Discretionary | 23.55% |
| 3 | Healthcare | 18.31% |
| 4 | Communication Services | 8.83% |
| 5 | Financials | 4.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Amphastar Pharmaceuticals
AMPH
$850M
| $24.6K | 0.01% |
655
+164
| +33% | +$5.38K |
|
|
AKRO
202
DELISTED
Akero Therapeutics
AKRO
| $24.3K | 0.01% |
634
+159
| +33% | +$7.09K |
|
203
Genmab
GMAB
$19.6B
| $23.9K | 0.01% |
632
+198
| +46% | +$7.61K |
|
|
KYNB
204
Kyntra Bio
KYNB
$28.7M
| $23.8K | 0.01% |
51
+13
| +34% | +$6.88K |
|
205
Xencor
XNCR
$1.72B
| $22.7K | 0.01% |
814
+205
| +34% | +$6.32K |
|
206
Kymera Therapeutics
KYMR
$9.48B
| $22.2K | 0.01% |
748
+191
| +34% | +$6.16K |
|
207
Ironwood Pharmaceuticals
IRWD
$714M
| $22K | 0.01% |
2,089
+531
| +34% | +$5.95K |
|
|
SWTX
208
DELISTED
SpringWorks Therapeutics
SWTX
| $21.8K | 0.01% |
847
+213
| +34% | +$6.22K |
|
209
Lam Research
LRCX
$408B
| $21.7K | 0.01% |
+410
| New | +$20.1K |
|
210
Veracyte
VCYT
$3.59B
| $21.7K | 0.01% |
972
+243
| +33% | +$5.87K |
|
|
FISV
211
Fiserv Inc
FISV
$27.4B
| $21.5K | 0.01% |
+190
| New | +$20.9K |
|
212
BioCryst Pharmaceuticals
BCRX
$2.71B
| $21.3K | 0.01% |
2,554
+661
| +35% | +$6.36K |
|
213
Edwards Lifesciences
EW
$53.6B
| $21.2K | 0.01% |
256
| – | – |
|
214
Aurinia Pharmaceuticals
AUPH
$2.06B
| $21.2K | 0.01% |
1,932
+488
| +34% | +$4.3K |
|
|
CVAC
215
DELISTED
CureVac
CVAC
| $21K | 0.01% |
3,008
+1,075
| +56% | +$9.37K |
|
|
KDNY
216
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $20.6K | 0.01% |
892
+243
| +37% | +$5.79K |
|
217
Pliant Therapeutics
PLRX
$66.3M
| $20.6K | 0.01% |
773
+278
| +56% | +$7.92K |
|
|
ATVI
218
DELISTED
Activision Blizzard
ATVI
| $20.3K | 0.01% |
+237
| New | +$18.4K |
|
|
MORF
219
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $20.2K | 0.01% |
536
+144
| +37% | +$5.31K |
|
220
Immunocore
IMCR
$1.77B
| $20K | 0.01% |
404
+142
| +54% | +$7.99K |
|
221
Micron Technology
MU
$1.03T
| $19.9K | 0.01% |
+330
| New | +$19.3K |
|
222
Arvinas
ARVN
$580M
| $19.7K | 0.01% |
722
+181
| +33% | +$5.72K |
|
223
Travere Therapeutics
TVTX
$5.86B
| $19.7K | 0.01% |
877
+225
| +35% | +$4.78K |
|
224
Syndax Pharmaceuticals
SNDX
$1.77B
| $19.6K | 0.01% |
928
+316
| +52% | +$7.86K |
|
225
CSX Corp
CSX
$92.8B
| $18.7K | 0.01% |
+624
| New | +$19.2K |
|
Similar funds
HA
JPM
CPO
LCI
GWM
JIP
RMC
GACM
China Universal Asset Management Company's Q1 2023 Portfolio in Review
As of Q1 2023, China Universal Asset Management Company held 456 positions worth $295M, up 19% from $249M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
China Universal Asset Management Company's Q1 2023 filing shows 65 new, 317 increased, 38 reduced and 9 closed positions. Its largest new stake was Baidu: 20,500 shares worth $3.09M. The largest sale was Pinduoduo, an estimated $7.85M.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- China Universal Asset Management Company's largest Q1 2023 buy was Baidu: 20,500 shares worth $3.09M.
- China Universal Asset Management Company added most to NVIDIA in Q1 2023, an estimated $6.09M increase.
- China Universal Asset Management Company's biggest Q1 2023 reduction was Pinduoduo, cutting an estimated $7.85M.
- China Universal Asset Management Company fully exited Tower Semiconductor in Q1 2023, selling an estimated $1.94M.
- China Universal Asset Management Company's ten largest holdings make up 32% of its $295M portfolio in Q1 2023.
- China Universal Asset Management Company opened 65 new positions and closed 9 in Q1 2023.
- China Universal Asset Management Company's portfolio value rose 19% quarter-over-quarter to $295M.
Based on China Universal Asset Management Company's 13F filing for Q1 2023, filed 28 Apr 2023.